Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:1728-1729
Published online before print June 12, 2003, doi: 10.1161/01.STR.0000078561.40741.B4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/7/1728    most recent
01.STR.0000078561.40741.B4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qureshi, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qureshi, A. I.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Stroke. 2003;34:1728.)
© 2003 American Heart Association, Inc.


Editorial Comment

Editorial Comment—Thromboembolic Events During Neuroendovascular Procedures

Adnan I. Qureshi, MD, Guest Editor

Cerebrovascular Program, Department of Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey, Newark, New Jersey


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Thromboembolic and ischemic complications occur frequently during and after endovascular procedures because of associated arterial injury and the thrombogenic characteristics of arterial catheters, contrast agents, and implanted devices such as coils and stents.1,2 With the growing use of endovascular procedures in neurosurgical practice, adequate knowledge of the basic pathophysiological and pharmacological principles that are involved is important.

When blood first contacts a foreign surface, the sequence of events initiated often ends in blood coagulation and thrombus formation.3 Initially, a thin layer of platelets and fibrinogen covers the surface of the foreign material. The magnitude of the initial reaction depends on the surface charge, chemical properties, and topographic features of the vascular device and the pattern of blood flow in the vicinity.1,3 The basic equipment used during endovascular procedures includes angiographic catheters, guidewires, and microcatheters. Several investigators have suggested that vascular catheters used for diagnostic and therapeutic purposes are not biologically inert but may serve as nidi for thrombosis.1,4 Anderson et al5 observed that guidewires (both stainless steel and Teflon-coated) also exhibited surface irregularities that promote platelet aggregation and fibrin deposition. Even contrast agents may promote clotting in catheters and syringes, placing patients at risk of thromboembolism.1,6 Gasperetti et al6 observed that the use of nonionic contrast material during coronary angioplasty was associated with a higher risk of intravascular thrombosis.

Both coils and stents are intravascularly implanted devices that invoke thrombogenic responses when placed in vessels. The coils most commonly used in endovascular procedures are platinum Guglielmi detachable coils.7 The purpose . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
StrokeHome page
A. I. Qureshi
Endovascular Revascularization of Symptomatic Acute Extracranial Internal Carotid Artery Occlusion
Stroke, November 1, 2005; 36(11): 2335 - 2336.
[Full Text] [PDF]